Skip to content
User

Lewis Sanders

Sanders Capital

Lewis Sanders GlaxoSmithKline PLC ADR stake

total: 132

Sanders Capital GSK trades

Total transactions:
3
New positions:
1
Sold out:
1
Added:
1
Held since:
2013 Q2 or earlier
Held for:
6+ quarters
Latest activity:
2014 Q4
According to 2026 Q2 report, Lewis Sanders doesn't hold any GlaxoSmithKline PLC ADR (GSK) shares. Sanders Capital has held GSK since at least 2013 Q2 with 2,240 shares in our earliest available record. Since at least 2013 Q2, Sanders Capital has made 2 more transactions.

When did Lewis Sanders sell GlaxoSmithKline PLC ADR (GSK)?

Lewis Sanders sold off the entire GlaxoSmithKline PLC ADR (GSK) position in 2014 Q4.

Estimated cost basis*

Weighted AVG buy price:
$66.49
Weighted AVG sell price:
$57.48

Lewis Sanders's historical trades in GlaxoSmithKline PLC ADR

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2014 Q4
0.00%
$57.48
-100% (-26,880)
2014 Q2
0.02%
$66.85
+1,100.00% (+24,640)
2013 Q2
0.00%
$62.50
new or own*
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.